IMCVX | VMVAX | IMCVX / VMVAX | |
Total Expense Ratio | 0.79 | 0.07 | 1,129% |
Annual Report Gross Expense Ratio | 0.80 | 0.07 | 1,143% |
Fund Existence | 14 years | 14 years | - |
Gain YTD | 2.540 | 5.198 | 49% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 3000 | 8,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 163M | 31B | 1% |
Annual Yield % from dividends | 0.90 | 2.22 | 41% |
Returns for 1 year | -5.82 | 7.67 | -76% |
Returns for 3 years | -0.42 | 17.51 | -2% |
Returns for 5 years | 20.04 | 65.15 | 31% |
Returns for 10 years | -17.21 | 87.87 | -20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BKRDX | 8.34 | 0.02 | +0.24% |
iShares Developed Real Estate Idx K | |||
FCGIX | 20.75 | 0.03 | +0.14% |
NYLI PineStone Global Equity Class I | |||
FLUTX | 28.26 | -0.06 | -0.21% |
Fidelity Advisor Stk Selec Lg Cp Val M | |||
JORSX | 16.29 | -0.10 | -0.61% |
JHancock Small Cap Core R6 | |||
UBVCX | 75.23 | -0.73 | -0.96% |
Undiscovered Managers Behavioral Val C |